Patient age, sex, weight, BMI, or HbA1c level did not affect if HS symptoms got better on semaglutide
The Precision Peptide Genetic Test examines 14 peptide pathways and 150+ genetic insights, including GLP1R rs6923761 variants that correlate with semaglutide receptor sensitivity
The severity of these side effects may depend on your injection dose and individual sensitivities
Liver Fat (MASLD) A Phase 2 trial showed retatrutide reduced liver fat by 82%
Weight loss tablets are expected to be a game changer, making GLP-1 treatments feel more accessible for a whole new group of people, especially those who dont like needles, or dont want to inject themselves every week
Acknowledgements This work was supported by the National Natural Science Foundation of China (81930008)